BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
unjha formulations ltd. stock

UNJHA FORMULATIONS LTD. Share Price

32.25 0.64 (2.02%)
Dec 11 2024 03:28 PM Pharmaceuticals NSE: UNJHAFOR

UNJHA FORMULATIONS LTD. Share Price Update

As of the latest trading session, UNJHA FORMULATIONS LTD. share price is currently at 32.25, which is up by 0.64 from its previous closing. Today, the stock has fluctuated between 30.17 and 33.99. Over the past year, UNJHA FORMULATIONS LTD. has achieved a return of 100.00 %. In the last month alone, the return has been 4.98 %. Read More...

UNJHA FORMULATIONS LTD. Performance

Day Range

Low30.17 High33.99
32.25

52 Week Range

Low 14.85 High 39.00
32.25

UNJHA FORMULATIONS LTD. Share Price

531762

UNJHAFOR

img img img img
No Data Available

Open Price

30.97

Prev. Close

31.60

Volume (Shares)

11240.00

Total traded value

3.68

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

UNJHA FORMULATIONS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 14.40
PE Ratio (TTM) 18.02
Book Value / Share 7.40
Beta 0.00
ROE 6.00%
EPS (TTM) 1.79
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.11

UNJHA FORMULATIONS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 3.78
Operating Expense 3.91
Net Profit -0.11
Net Profit Margin (%) -2.91
Earnings Per Share (EPS) -0.02
EBITDA -0.09
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 3.95
Operating Expense 3.25
Net Profit 0.70
Net Profit Margin (%) 17.72
Earnings Per Share (EPS) 1.56
EBITDA 0.72
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 4.43
Operating Expense 4.43
Net Profit -0.18
Net Profit Margin (%) -4.06
Earnings Per Share (EPS) -0.39
EBITDA 0.07
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 5.55
Operating Expense 5.15
Net Profit 0.39
Net Profit Margin (%) 7.02
Earnings Per Share (EPS) 0.87
EBITDA 0.41
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 4.76
Operating Expense 4.89
Net Profit -0.12
Net Profit Margin (%) -2.52
Earnings Per Share (EPS) 0.14
EBITDA -0.09
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 18.50
Operating Expense 18.06
Net Profit 0.28
Net Profit Margin (%) 1.51
Earnings Per Share (EPS) 0.62
EBITDA 0.59
Effective Tax Rate (%) 37.77
Particulars MAR 2023 (Values in Cr)
Revenue 13.15
Operating Expense 12.86
Net Profit 0.28
Net Profit Margin (%) 2.12
Earnings Per Share (EPS) 0.63
EBITDA 0.47
Effective Tax Rate (%) 15.15
Particulars MAR 2022 (Values in Cr)
Revenue 14.16
Operating Expense 14.05
Net Profit 0.25
Net Profit Margin (%) 1.76
Earnings Per Share (EPS) 0.56
EBITDA 0.51
Effective Tax Rate (%) 16.66
Particulars MAR 2021 (Values in Cr)
Revenue 9.96
Operating Expense 10.07
Net Profit 0.10
Net Profit Margin (%) 1.00
Earnings Per Share (EPS) 0.23
EBITDA 0.35
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 10.60
Operating Expense 10.54
Net Profit 0.31
Net Profit Margin (%) 2.92
Earnings Per Share (EPS) 0.69
EBITDA 0.51
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 6.10
ROE % 6.00
ROCE % 10.71
Total Debt to Total Equity 0.00
EBITDA Margin 3.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.48
ROE % 6.00
ROCE % 8.35
Total Debt to Total Equity 0.00
EBITDA Margin 3.57
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4.84
ROE % 5.35
ROCE % 9.20
Total Debt to Total Equity 0.00
EBITDA Margin 3.60
Particulars MAR 2021 (Values in Cr)
Book Value / Share 4.28
ROE % 2.14
ROCE % 5.78
Total Debt to Total Equity 0.00
EBITDA Margin 3.51
Particulars MAR 2020 (Values in Cr)
Book Value / Share 4.05
ROE % 6.63
ROCE % 9.20
Total Debt to Total Equity 0.00
EBITDA Margin 4.81
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.87
Total Assets 4.93
Total Liabilities 4.93
Total Equity 2.73
Share Outstanding 4480500
Price to Book Ratio 3.10
Return on Assets (%) 5.63
Return on Capital (%) 10.18
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 3.40
Total Liabilities 3.40
Total Equity 2.45
Share Outstanding 4480500
Price to Book Ratio 2.28
Return on Assets (%) 8.28
Return on Capital (%) 11.52
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.42
Total Assets 3.45
Total Liabilities 3.45
Total Equity 2.17
Share Outstanding 4480500
Price to Book Ratio 1.94
Return on Assets (%) 7.30
Return on Capital (%) 11.63
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 3.52
Total Liabilities 3.52
Total Equity 1.91
Share Outstanding 4480500
Price to Book Ratio 1.99
Return on Assets (%) 2.93
Return on Capital (%) 5.4
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.93
Total Assets 3.71
Total Liabilities 3.71
Total Equity 1.81
Share Outstanding 4480500
Price to Book Ratio 1.42
Return on Assets (%) 8.30
Return on Capital (%) 16.99
Particulars MAR 2024 (Values in Cr)
Net Income 0.45
Cash from Operations 1.07
Cash from Investing -0.10
Cash from Financing -0.05
Net change in Cash 0.86
Free Cash Flow 1.18
Particulars MAR 2023 (Values in Cr)
Net Income 0.32
Cash from Operations -0.21
Cash from Investing -0.09
Cash from Financing -0.05
Net change in Cash -0.41
Free Cash Flow -0.10
Particulars MAR 2022 (Values in Cr)
Net Income 0.25
Cash from Operations 0.40
Cash from Investing -0.02
Cash from Financing 0.00
Net change in Cash 0.25
Free Cash Flow 0.43
Particulars MAR 2021 (Values in Cr)
Net Income 0.10
Cash from Operations -0.53
Cash from Investing -0.06
Cash from Financing 0.00
Net change in Cash -0.76
Free Cash Flow -0.46
Particulars MAR 2020 (Values in Cr)
Net Income 0.30
Cash from Operations 0.50
Cash from Investing -0.10
Cash from Financing 0.00
Net change in Cash 0.28
Free Cash Flow 0.61
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 37.87 3.59 505.01 37.54 / 77.70
BLISS GVS PHARMA LTD 155.50 19.46 1.62 1637.91 92.25 / 172.40
CIPLA LTD 1455.65 25.47 4.14 117560.12 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 414.95 144.08 4.20 1221.24 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2328.95 49.21 23.58 39453.82 1664.75 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 57.30 11.20 505.01 37.54 / 77.70
AMRUTAJAN HEALTH LTD 753.60 45.84 7.31 2178.71 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6634.15 128.84 24.41 16585.38 4050.15 / 8139.85
BLISS GVS PHARMA LTD 155.50 20.27 1.59 1637.91 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 31.50
  • 26 Days 30.40
  • 10 Days 30.80
  • 50 Days 30.00
  • 12 Days 30.40
  • 100 Days 28.60
  • 20 Days 30.60
  • 200 Days 18.50
31.24
PIVOT
First Resistance 32.25
Second Resistance 32.90
Third Resistance 33.91
First Support 30.59
Second Support 29.58
Third Support 28.93
RSI 56.09
MACD 0.06
Commodity Channel Index (CCI) 90.75
ADX 10.63
Williams % R -23.97

Over 1 Month

down

4.98

Over 3 Months

down

15.53

Over 6 Months

down

34.12

Over 1 Year

down

100.00

Over 3 Years

down

46.74

Over 5 Years

down

31.61

UNJHA FORMULATIONS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

UNJHA FORMULATIONS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
63.07
Promoter Holdings
36.92
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Jashodaben Shambhubhai Patel Shareholding of Promoter and Promoter Group 739900.0 16.51
Krutiben Mayankkumar Patel Shareholding of Promoter and Promoter Group 667251.0 14.89
Urveshkumar Shambhbhai Patel Shareholding of Promoter and Promoter Group 162273.0 3.62
Neenaben Urveshkumar Patel Shareholding of Promoter and Promoter Group 85000.0 1.9
Esha Mayank Patel Public Shareholding 71560.0 1.6
Manish Patel Public Shareholding 59058.0 1.32
Deep Mayank Patel Public Shareholding 57778.0 1.29
Narveer Yadav Public Shareholding 52501.0 1.17
Jatinkumar Babulal Patel Public Shareholding 47400.0 1.06

UNJHA FORMULATIONS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About UNJHA FORMULATIONS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by UNJHA FORMULATIONS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Unjha Formulations Ltd?

Answer Field

The share price of Unjha Formulations Ltd for NSE is ₹ 0.00 and for BSE is ₹ 32.25.

What is the Market Cap of Unjha Formulations Ltd?

Answer Field

The market cap of Unjha Formulations Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 14.40 Cr. as of now.

What is the 52 Week High and Low of Unjha Formulations Ltd?

Answer Field

The 52 Week High and Low of Unjha Formulations Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 39.00 and ₹ 14.85.

How to Buy Unjha Formulations Ltd share?

Answer Field

You can trade in Unjha Formulations Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Unjha Formulations Ltd?

Answer Field

The 1 year returns on the stock has been 100.00%.

What is the Current Share Price of Unjha Formulations Ltd?

Answer Field

Unjha Formulations Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 32.25 as on Dec 11 2024 03:28 PM.

What is the Market Cap of Unjha Formulations Ltd Share?

Answer Field

The market cap of Unjha Formulations Ltd for NSE ₹ 0.0 & for BSE ₹ 14.40 as on Dec 11 2024 03:28 PM.

What is the P/E Ratio of Unjha Formulations Ltd Share?

Answer Field

As on Dec 11 2024 03:28 PM the price-to-earnings (PE) ratio for Unjha Formulations Ltd share is 18.02.

What is the PB ratio of Unjha Formulations Ltd Share?

Answer Field

As on Dec 11 2024 03:28 PM, the price-to-book (PB) ratio for Unjha Formulations Ltd share is 7.40.

How to Buy Unjha Formulations Ltd Share?

Answer Field

You can trade in Unjha Formulations Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Unjha Formulations Ltd Share on Bajaj Broking App?

Answer Field

To buy Unjha Formulations Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Unjha Formulations Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader